Crossmark

The Efficacy of Dupilumab Largely Exceeds the 6-Month Treat-to-target Goals: An Analysis in an Atopic Dermatitis Referral Center

Crossref DOI link: https://doi.org/10.1016/j.ad.2023.10.062

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Valente, C.

Figueira Vilela, B.

Paiva-Lopes, M.J.

Duarte, B.
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-03-07
More Information

This article is maintained by: Elsevier

Article Title: The Efficacy of Dupilumab Largely Exceeds the 6-Month Treat-to-target Goals: An Analysis in an Atopic Dermatitis Referral Center

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2023.10.062

Content Type: simple-article

Copyright: © 2025 AEDV. Published by Elsevier España, S.L.U.